Abstract submission is now closed and currently, abstracts are under peer review. The first review process will end at the end of January 2022 and will be followed by a quality assurance review. We hope to be able to inform applicants of the acceptance status of their abstract by the end of February.
You will be able to submit abstracts via our online system until November 10, 2021 on ConfTool Pro. Abstracts MUST be submitted electronically (via the online system) by the deadline of October 31, 2021. Abstracts submitted by fax or by email CANNOT be accepted.
Abstracts received after the submission deadline cannot be accepted and therefore will not be considered for the programme or for publication.
Submission of an abstract does not guarantee its acceptance.
All presenters of accepted abstracts are expected to have financial resources to cover all expenses related to the Conference: registration fee, travel and accommodation charges (except for bursary applicants).
By submitting the abstract, the author authorizes the organizer to publish his/her abstract in the Conference proceedings.
Resubmittal of already submitted abstracts can only be done before the new deadline of November 10, 2021.
No author can participate (in any capacity) in more than 3 sessions.
All abstracts must be written in English. (Should your abstract be accepted for a presentation you must be able to give your presentation in English and answer the questions from the audience.)
Abstracts should contain no more than 500 words. The system will automatically let you know whether or not you have complied with this rule.
Tables and figures cannot be inserted.
When you submit, PLEASE BE SURE TO CHOOSE THE MOST APPROPRIATE THEME AND THE MOST APPROPRIATE MODALITY.
If you have already submitted an abstract and have asked us to hold it until the June 2022 conference you will have an opportunity to update this submission. Similarly, if you need to make changes to a submission, an opportunity for this will also be provided to you. A separate email will be sent to you regarding the above.